What has FDA cited under ICH Q1D?

1 DSRV article cite ICH Q1D. Enforcement cases behind them: Recurring FDA stability program observations under 21 CFR §211.166 and excursion-handling expectations informed by ICH Q1A(R2). Inspection exposure across them: 1 moderate.

What does DSRV recommend for ICH Q1D?

From the newest article (When Stability Data Gaps Become Inspection Exposure): The inspection question is never whether gaps exist - it is whether each gap weakens the shelf-life justification and whether you documented how you managed it. DSRV is decision support, not legal advice; verify against the official source each article names.

Browse by regulation1 article · 1 moderate

ICH Q1D

Every DSRV article whose Regulatory Snapshot cites ICH Q1D: the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set

What has FDA cited under ICH Q1D?: 1 DSRV article cite ICH Q1D. Enforcement cases behind them: Recurring FDA stability program observations under 21 CFR §211.166 and excursion-handling expectations informed by ICH Q1A(R2). Inspection exposure across them: 1 moderate.
What does DSRV recommend for ICH Q1D?: From the newest article (When Stability Data Gaps Become Inspection Exposure): The inspection question is never whether gaps exist - it is whether each gap weakens the shelf-life justification and whether you documented how you managed it. DSRV is decision support, not legal advice; verify against the official source each article names.

May 20267 min readModerate exposurecited as a tag
When Stability Data Gaps Become Inspection Exposure
Not every stability gap is equal. A missing time point, an unmanaged excursion, or an under-powered trend can quietly become an inspection finding. Here is how to triage which gaps create real exposure.
Case
Recurring FDA stability program observations under 21 CFR §211.166 and excursion-handling expectations informed by ICH Q1A(R2).
DSRV take
The inspection question is never whether gaps exist - it is whether each gap weakens the shelf-life justification and whether you documented how you managed it.

Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under ICH Q1D. DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about ICH Q1D

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.